In Prevention of Migraine Pronara 40mg/5mg Capsule helps improve the flow of blood in your brain and prevents abnormal activity of muscles that triggers migraines. It is a very effective medicine for preventing migraine attacks, however, it does not treat an attack that has already started. By preventing and reducing the frequency migraine attacks, the medicine can help you carry out your daily activities and improve your quality of life.
It is unsafe to consume alcohol with Pronara 40mg/5mg Capsule.
Pronara 40mg/5mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Pronara 40mg/5mg Capsule during breastfeeding is not available. Please consult your doctor.
Pronara 40mg/5mg Capsule may cause side effects which could affect your ability to drive. Pronara 40mg/5mg Capsule may cause visual disturbances, hallucinations, fatigue, mental confusion, dizziness or tiredness. This may affect your driving ability.
Pronara 40mg/5mg Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Pronara 40mg/5mg Capsule may not be needed in these patients. Please consult your doctor.
Pronara 40mg/5mg Capsule should be used with caution in patients with liver disease. Dose adjustment of Pronara 40mg/5mg Capsule may be needed. Please consult your doctor. Regular monitoring of blood pressure is advisable for dose adjustment.
If you miss a dose of Pronara 40mg/5mg Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Diva Health Care || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Unimarck Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Mabril Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zelnic Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cnscure India Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Anax Lifescience || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Masson Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zentiva Pharmaceutical || ₹14.5/tablet (25% cheaper)